当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 现金流量表

亿帆医药

(002019)

  

流通市值:78.86亿  总市值:113.85亿
流通股本:8.43亿   总股本:12.16亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,610,574,244.991,293,722,368.934,972,807,608.063,864,821,449.72
  收到的税费返还29,898,863.5913,997,112.5957,439,778.0742,714,029.08
  收到其他与经营活动有关的现金25,487,356.6760,156,223.22325,867,877.45143,665,540.63
  经营活动现金流入小计2,665,960,465.251,367,875,704.745,356,115,263.584,051,201,019.43
  购买商品、接受劳务支付的现金1,085,764,244.38513,219,894.622,351,960,565.991,959,738,022.41
  支付给职工以及为职工支付的现金456,407,888.41245,094,744.34817,038,414.03586,589,654.6
  支付的各项税费171,061,648.8673,383,525.2425,833,123.31281,444,521.8
  支付其他与经营活动有关的现金359,216,619.46251,339,322.841,302,916,875.42897,277,833.33
  经营活动现金流出小计2,072,450,401.111,083,037,4874,897,748,978.753,725,050,032.14
  经营活动产生的现金流量净额593,510,064.14284,838,217.74458,366,284.83326,150,987.29
二、投资活动产生的现金流量:
  收回投资收到的现金50,000,000-80,590,053.7780,901,108
  取得投资收益收到的现金845,468.44,000133,9001,318,594.64
  处置固定资产、无形资产和其他长期资产收回的现金净额11,218,959.598,995,530.4124,413,236.47,420,496.27
  投资活动现金流入小计62,064,427.998,999,530.41105,137,190.1789,640,198.91
  购建固定资产、无形资产和其他长期资产支付的现金377,167,958.5215,715,287.35559,232,140.2433,009,680.76
  投资支付的现金50,000,000---
  取得子公司及其他营业单位支付的现金---1,000,000
  投资活动现金流出小计427,167,958.5215,715,287.35559,232,140.2434,009,680.76
  投资活动产生的现金流量净额-365,103,530.51-206,715,756.94-454,094,950.03-344,369,481.85
三、筹资活动产生的现金流量:
  取得借款收到的现金716,542,199.26361,846,346.491,856,928,064.21,618,165,592.37
  收到其他与筹资活动有关的现金--1,028,773.39737,781.11
  筹资活动现金流入小计716,542,199.26361,846,346.491,857,956,837.591,618,903,373.48
  偿还债务支付的现金601,358,224342,560,478.621,776,066,217.051,394,676,341.59
  分配股利、利润或偿付利息支付的现金167,235,960.7513,170,207.38171,577,683.56159,774,825.51
  其中:子公司支付给少数股东的股利、利润19,600,000---
  支付其他与筹资活动有关的现金6,179,406.083,299,162.9824,484,414.7910,465,132.19
  筹资活动现金流出小计774,773,590.83359,029,848.981,972,128,315.41,564,916,299.29
  筹资活动产生的现金流量净额-58,231,391.572,816,497.51-114,171,477.8153,987,074.19
四、汇率变动对现金及现金等价物的影响-24,481,532.3-14,429,757.72-3,969,598.42-2,301,795.45
五、现金及现金等价物净增加额145,693,609.7666,509,200.59-113,869,741.4333,466,784.18
  加:期初现金及现金等价物余额663,768,116.47663,768,116.47777,637,857.9777,637,857.9
  期末现金及现金等价物余额809,461,726.23730,277,317.06663,768,116.47811,104,642.08
补充资料:
  净利润187,392,598.33-373,451,729.24-
  资产减值准备39,897,032.37-81,644,901.72-
  固定资产和投资性房地产折旧68,363,957.9-118,295,699.88-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧68,363,957.9-118,295,699.88-
  无形资产摊销108,723,267.06-216,741,066.93-
  长期待摊费用摊销3,127,658.58-13,513,076.77-
  处置固定资产、无形资产和其他长期资产的损失1,528,142.97--12,695,234.82-
  固定资产报废损失518,598.2-1,372,279.15-
  公允价值变动损失314,610.6-143,103.71-
  财务费用23,036,056.47-53,039,094.91-
  投资损失12,225,169.97-27,309,932.03-
  递延所得税-11,835,781.77--19,849,706.76-
  其中:递延所得税资产减少-9,751,806.37--13,013,324.67-
    递延所得税负债增加-2,083,975.4--6,836,382.09-
  存货的减少106,319,695.22--202,111,610.4-
  经营性应收项目的减少64,431,021.19--109,042,870.66-
  经营性应付项目的增加-10,471,471.04--115,234,067.3-
  其他-5,038,568.38-18,054,927.05-
  现金的期末余额809,461,726.23-663,768,116.47-
  减:现金的期初余额663,768,116.47-777,637,857.9-
  现金及现金等价物的净增加额145,693,609.76--113,869,741.43-
公告日期2026-08-292026-04-242026-04-242025-10-31
审计意见(境内)标准无保留意见
TOP↑